Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer

The purpose of the study is to determine the safety, tolerability and maximum tolerated dose of Urelumab in combination with Cetuximab in patients with Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Squamous Cell Carcinoma of the Head and Neck.

本研究旨在确定乌瑞单抗（Urelumab）联合西妥昔单抗（Cetuximab）用于晚期/转移性结直肠癌或晚期/转移性头颈部鳞状细胞癌患者时的安全性、耐受性及最大耐受剂量。